Arch Biopartners Inc. (TSXV:ARCH)
0.9700
+0.0200 (2.11%)
Oct 24, 2025, 2:12 PM EDT
Arch Biopartners Market Cap
Arch Biopartners has a market cap or net worth of CAD 62.96 million as of October 24, 2025. Its market cap has decreased by -38.71% in one year.
Market Cap
62.96M
Enterprise Value
65.53M
Revenue
-84.71K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.97
Market Cap Chart
Since January 21, 2011, Arch Biopartners's market cap has increased from 33.37M to 62.96M, an increase of 88.66%. That is a compound annual growth rate of 4.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2025 | 61.14M | -51.53% |
| Dec 31, 2024 | 126.14M | 36.32% |
| Dec 29, 2023 | 92.53M | -47.32% |
| Dec 30, 2022 | 175.66M | -18.54% |
| Dec 31, 2021 | 215.63M | 145.71% |
| Dec 29, 2020 | 87.76M | 53.80% |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 16, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 3.12B |
| Green Thumb Industries | 2.44B |
| dentalcorp Holdings | 2.17B |
| Trulieve Cannabis | 2.02B |
| Sienna Senior Living | 1.84B |
| Extendicare | 1.35B |
| Cronos Group | 1.32B |
| WELL Health Technologies | 1.28B |